5+ mon, 3+ week ago   (144+ words) Pharmaceutical Executive Proving Coaching ROI: A Pharma Field-Force Transformation Case Study: See how a leading pharma team turned coaching into measurable performance gains with clear ROI. This case study breaks down how they standardized learning, proved impact, and significantly boosted…...

7+ mon, 1+ week ago   (417+ words) Trialynx CEO Angela Schwab discusses where she saw AI succeeding and failing at the healthcare conference. Pharmaceutical Executive: What AI trends did you see at the 2026 JP Morgan Healthcare Conference?Angela Schwab: Good and bad. You see a lot of…...

3+ mon, 6+ hour ago   (118+ words) As the executive insights in our June issue illustrate, breakthroughs in pharma are rarely the result of a single discovery but are the product of organizations — and people — designed to keep moving forward. A recurring theme running throughout biopharma today…...

1+ mon, 3+ week ago   (381+ words) AI adoption in pharma drops sharply in the domains that matter most for discovery. The gap between what leaders are funding and what scientists are willing to act on is the risk underlying one of the largest technology bets our…...

2+ mon, 3+ week ago   (571+ words) 5 Prime Sciences CEO discusses how simply building a massive data set can cause more problems than it solves during clinical trials. As technology improves, collecting clinical data has become much easier. However, this provides both benefits and adds new difficulties....

6+ mon, 6+ day ago   (918+ words) Pharmaceutical Executive Digital health technologies like Apple Health and Oura have completely transformed how we think about hitting our health goals. These wearables have mastered the art of human motivation. Data, such as step counts, trains us to compete against…...

10+ mon, 3+ week ago   (505+ words) The importance for pharma in recognizing integrated data sources as necessary infrastructure—not just a competitive edge. How AI is Shaping KOL and DOL Identification Rethinking Audience Modeling: AI, Regulations, & More The solution lies not in choosing between business rules-based…...

2+ mon, 3+ week ago   (234+ words) With clinical trial data exploding to nearly 6 million datapoints, eClinical Solutions' CEO and Co-founder, Raj Indupuri makes the case for price transparency and a measurable ROI in clinical data technology. Phase III trial data volume has grown sixfold to over…...

1+ mon, 2+ week ago   (544+ words) Pharmaceutical Executive The Ron Lanton Report: The Human Bottleneck In this episode, Ron Lanton argues that healthcare's next constraint isn't capital or technology but rather people. This episode of The Ron Lanton Report examines why the next phase of healthcare…...

3+ mon, 1+ week ago   (481+ words) Prescryptive Health’s chief commercial officer discusses the results of a market access survey that asked industry executives about DTC models, affordability, and patient access. In a survey of Pharmaceutical Executive and Pharmaceutical Commerce readers, respondents were asked a series of…...